Retraction notice to 'MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling' [Biomed. Pharmacother., vol. 106, October 2018, Pages 483–490]

Retraction notice to 'MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling' [Biomed. Pharmacother., vol. 106, October 2018, Pages 483–490]

Bibliographic Details
Main Authors:	Ningjia Cao, Liang Mu, Wei Yang, Li Liu, Liang Liang, Hong Zhang
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Biomedicine & Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332223005358

Similar Items

Retraction notice to “Stress induced phosphoprotein 1 promotes tumor growth and metastasis of melanoma via modulating JAK2/STAT3 pathway” [Biomed. Pharmacother. 116 (2019) 108962]
by: Xiaoyan Sun, et al.
Published: (2023-04-01)

Retraction Notice to “Pharmacological evaluation of continentalic acid for antidiabetic potential” [Biomed. Pharmacother. 138 (2021) 111411]
by: Iqra Liaquat, et al.
Published: (2024-01-01)

Retraction notice to “miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1” [Biomed. Pharmacother. 106 (2018) 1072–1081]
by: Huixing Deng, et al.
Published: (2023-06-01)

Retraction notice to “Effect of an aqueous extract of Averrhoa carambola L. on endothelial function in rats with ventricular remodelling” [Biomed. Pharmacother. 121 (2019) 109612]
by: Xingmei Liang, et al.
Published: (2024-04-01)

Retraction notice to “Salidroside alleviates cigarette smoke-induced COPD in mice” [Biomed. Pharmacother. 86 (2017) 155–161]
by: Fen Luo, et al.
Published: (2023-04-01)

Retraction notice to “The effect of microRNA-328 antagomir on erectile dysfunction instreptozotocin-induced diabetic rats” [Biomed. Pharmacother. 92 (2017) 888–895]
by: Dong-Shui Li, et al.
Published: (2023-08-01)

Retraction notice to “MicroRNA-29a inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by repressing STAT3” [Biomed. Pharmacother. 96 (2017) 173–181]
by: Jinxiang Liu, et al.
Published: (2023-12-01)

Retraction notice to “Down-regulation of microRNA-21 reduces inflammation and podocyte apoptosis in diabetic nephropathy by relieving the repression of TIMP3 expression” [Biomed. Pharmacother. 108 (2018) 7–14]
by: Xiaoping Chen, et al.
Published: (2023-08-01)

Retraction notice to “Matrine inhibits hypoxia/reoxygenation-induced apoptosis of cardiac microvascular endothelial cells in rats via the JAK2/STAT3 signaling pathway” [Biomed. Pharmacother. 106 (2018) 117–124]
by: Xue-Bin Zhao, et al.
Published: (2023-06-01)

Retraction notice to 'Neferine inhibits proliferation, migration and invasion of U251 glioma cells by down-regulation of miR-10b' [Biomed. Pharmacother. 109 (2019) 1032–1040]
by: Hua-Xin Liang, et al.
Published: (2021-12-01)

Retraction notice to 'Potential role of andrographolide in the proliferation of osteoblasts mediated by the ERK signaling pathway' [Biomed. Pharmacother. 83 (2016) 1335–1344]
by: Bo Li, et al.
Published: (2023-07-01)

Retraction notice to “Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]” [Biomed. Pharmacother. 152 (2022) 113213]
by: Lanqing Cao, et al.
Published: (2023-04-01)

Retraction notice to “Targeted inhibition of Six1 attenuates allergic airway inflammation and remodeling in asthmatic mice” [Biomed. Pharmacother. 84 (2016) 1820–1825]
by: Zhao-Chuan Yang, et al.
Published: (2024-02-01)

Retraction notice to “MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314–1320]
by: Dacheng Wen, et al.
Published: (2023-11-01)

Retraction notice to “POLD1 deficiency is involved in cognitive function impairment in AD patients and SAMP8 mice” [Biomed. Pharmacother. 114 (2019) 108833]
by: Shichao Gao, et al.
Published: (2023-04-01)

Retraction notice to “Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis” [Biomed. Pharmacother. 106 (2018) 156–162]
by: Huan Xia, et al.
Published: (2023-12-01)

Retraction notice to: “microRNA-128 enhances neuroprotective effects of dexmedetomidine on neonatal mice with hypoxic-ischemic brain damage by targeting WNT1” [Biomed. Pharmacother. 113 (2019) 108671]
by: Hua Fang, et al.
Published: (2023-09-01)

Retraction notice to “Repression of long non-coding RNA MEG3 restores nerve growth and alleviates neurological impairment after cerebral ischemia-reperfusion injury in a rat model” [Biomed. Pharmacother. 111 (2019) 1447–1457]
by: Dong You, et al.
Published: (2023-08-01)

Retraction Notice to “Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats” [Biomed. Pharmacother. 142 (2021) 111666]
by: Nada H. Eisa, et al.
Published: (2024-01-01)

EAA483 - BI CONSTRUCTION MANAGEMENT. OCTOBER 2004
by: PPKAW, Pusat Pengajian Kejuruteraan Awam
Published: (2004)

Retraction notice to “MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14” [Biomed. Pharmacother. 98 (2018) 636–642]
by: Qi Li, et al.
Published: (2024-04-01)

Retraction notice to “miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer” [Biomed. Pharmacother. 95 (2017) 1718–1724]
by: Yuanqiang Lin, et al.
Published: (2024-02-01)

Retraction notice to “MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1” [Biomed. Pharmacother. 102 (2018) 988–995]
by: Rui Li, et al.
Published: (2023-08-01)

CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt/cadherin axis
by: Mu Yang, et al.
Published: (2022-07-01)

Retraction notice to “LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p” [Biomed. Pharmacother. 114 (2019) 108862]
by: Songyang Liu, et al.
Published: (2024-02-01)

Retraction notice to “ATPase inhibitory factor 1 is a prognostic marker and contributes to proliferation and invasion of human gastric cancer cells” [Biomed. Pharmacother. 70 (2015) 90–96]
by: Tao Yin, et al.
Published: (2023-04-01)

Corrigendum to: “Mitoquinone ameliorated airway inflammation by stabilizing β-catenin destruction complex in a steroid-insensitive asthma model” [Biomed. Pharmacother. vol. 162 (2023) 114680]
by: Junwen Huang, et al.
Published: (2023-09-01)

Retraction notice to: 'LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis' Biomed. Pharmacother. 125 (2020) 110039
by: Dacheng Wen, et al.
Published: (2023-10-01)

Corrigendum to “Valproate, divalproex, valpromide: Are the differences in indications justified?” [Biomed. Pharmacother., 158 (2023) 114051]
by: Clément Delage, et al.
Published: (2023-12-01)

Corrigendum to “Effects of oligonol on the submandibular gland in ovariectomized rats” [Biomed. Pharmacother. 141 (2021) 111897]
by: Jeong Hun Kim, et al.
Published: (2023-09-01)

Corrigendum to: “Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis”, [Biomed. Pharmacother., 161; (2023): 114472]
by: Liang Shan, et al.
Published: (2023-06-01)

Retraction notice to “MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway” [Biomed. Pharmacother. 107 (2018) 1744–1753]
by: Tao Wang, et al.
Published: (2023-04-01)

Retraction notice to “miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells” [Biomed. Pharmacother. 95 (2017) 120–128]
by: Wei Cai, et al.
Published: (2023-04-01)

Retraction notice to “Angelica polysaccharide protects PC-12 cells from lipopolysaccharide-induced injury via down-regulating microRNA-223” [Biomed. Pharmacother. 108 (2018) 1320–1327]”
by: Ran Li, et al.
Published: (2023-04-01)

Corrigendum to “Anti-hypertrophy effect of atorvastatin on myocardium depends on AMPK activation-induced miR-143-3p suppression via Foxo1” [Biomed. Pharmacother. 106 (2018) 1390-1395]
by: Bo Yu, et al.
Published: (2024-02-01)

Corrigendum to “Steatosis in metabolic diseases: A focus on lipolysis and lipophagy” [Biomed. Pharmacother. 160 (2023) 114311]
by: Xingtao Zhao, et al.
Published: (2023-07-01)

Loss of ctnnd2b affects neuronal differentiation and behavior in zebrafish
by: Raquel Vaz, et al.
Published: (2023-07-01)

Retraction notice to “MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)” [Biomed. Pharmacother. 76 (2015) 82–93]
by: Yu Mao, et al.
Published: (2024-02-01)

Retraction notice to “Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN” [Biomed. Pharmacother. 109 (2019) 2035–2042]
by: Yan Dong, et al.
Published: (2023-11-01)

Retraction notice to “The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells” [Biomed. & Pharmacother. 96 (2017) 1324–1334]
by: Pei-Ying Jin, et al.
Published: (2023-07-01)